← Back to CoursesMolecular Biology: Advanced

Neuroanatomy Explorer

Drag to rotate · scroll to zoom · click regions to explore

View
Loading 3D model…

Click a region
to explore it

Memory Deck

Flip each card and rate whether you knew it. Your score is saved.

Term
Definition

Deck complete — score saved.

Match the Pairs

Match each term to its definition. Finish the board to earn your score.

All matched — score saved.

Concept Constellation

Every key idea in this course, mapped as an explorable 3D constellation. Drag to rotate, scroll to zoom, click a node.

Click a node to read its definition.

Molecular Mechanisms in Disease, Cancer, and Therapeutic Design

Manual: General · Subject: Molecular Biology

Connects molecular defects to disease phenotypes and reviews how mechanisms guide targeted therapies.

From Mechanism to Medicine

Disease logic

Many diseases can be understood as failures in genome maintenance, RNA processing, signaling, proteostasis, or regulatory control. Molecular insight enables rational target selection and biomarker development.

Examples of molecular pathology

Cancer

  • Accumulation of driver mutations
  • Altered signaling, transcription, and DNA repair

Inherited disease

  • Loss of a specific gene function
  • Allele-specific or pathway-specific defects

Therapeutic modalities

Small molecules
Modulate enzyme activity or protein interactions
Antisense oligonucleotides
Alter RNA processing or abundance
RNA interference
Suppress target expression
Gene therapy
Add or replace genetic information
Genome editing
Correct or reprogram sequence
ℹ️

Precision medicine

Mechanism-based biomarkers can identify which patients are likely to benefit from a therapy and which resistance routes may emerge.

Why are driver mutations especially important in cancer biology?

What is a molecular biomarker?

Therapy design considerations

QuestionWhy it matters
Target specificityMinimizes off-target toxicity
DeliveryDetermines whether the therapeutic reaches the right cells
ResistanceShapes durability of response
Biomarker selectionEnables patient stratification

Which therapeutic strategy most directly aims to change RNA processing rather than protein activity?

Why is understanding mechanism essential for designing targeted therapy?